Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay Popat

Showing results (161-170 of 273) with videos related to

Pageof 28
Sort By:
European Journal of Cancer (Oxford, England : 1990)|June 15, 2022
Up-front cell-free DNA next generation sequencing improves target identification in UK first line advanced non-small cell lung cancer (NSCLC) patientsWanyuan Cui, Charlotte Milner-Watts, Hazel O'Sullivan, et al.
Cell Reports. Medicine|October 10, 2023
MesoGraph: Automatic profiling of mesothelioma subtypes from histological imagesMark Eastwood, Heba Sailem, Silviu Tudor Marc, et al.
Artificial Intelligence in Medicine|September 6, 2023
Malignant Mesothelioma subtyping via sampling driven multiple instance prediction on tissue image and cell morphology dataMark Eastwood, Silviu Tudor Marc, Xiaohong Gao, et al.
Lung Cancer (Amsterdam, Netherlands)|January 27, 2022
A pilot of Blood-First diagnostic cell free DNA (cfDNA) next generation sequencing (NGS) in patients with suspected advanced lung cancerWanyuan Cui, Charlotte Milner-Watts, Terri P McVeigh, et al.
BMC Cancer|March 9, 2021
Correction to: Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic diseaseDearbhaile Catherine Collins, Raghav Sundar, Anastasia Constantinidou, et al.
Clinical Lung Cancer|July 11, 2017
LUME-Meso: Design and Rationale of the Phase III Part of a Placebo-Controlled Study of Nintedanib and Pemetrexed/Cisplatin Followed by Maintenance Nintedanib in Patients With Unresectable Malignant Pleural MesotheliomaGiorgio V Scagliotti, Rabab Gaafar, Anna K Nowak, et al.
BMC Cancer|December 10, 2020
Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic diseaseDearbhaile Catherine Collins, Raghav Sundar, Anastasia Constantinidou, et al.
Lung Cancer (Amsterdam, Netherlands)|January 15, 2026
Nintedanib as switch maintenance treatment in malignant pleural mesothelioma (NEMO): A double-blind randomized phase II trial (EORTC-08112-LCG)Omar Abdel-Rahman, Paul Taylor, Mary O'Brien, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 16, 2016
A Validation Study for the Use of ROS1 Immunohistochemical Staining in Screening for ROS1 Translocations in Lung CancerPatrizia Viola, Manisha Maurya, James Croud, et al.
Oncology|April 16, 2016
Characterisation of the Phosphatidylinositol 3-Kinase Pathway in Non-Small Cell Lung Cancer Cells Isolated from Pleural EffusionsMartina Puglisi, Adam Stewart, Parames Thavasu, et al.
Pageof 28

Showing results (161-170 of 273) with videos related to

Sort By:
Pageof 28
European Journal of Cancer (Oxford, England : 1990)|June 15, 2022
Up-front cell-free DNA next generation sequencing improves target identification in UK first line advanced non-small cell lung cancer (NSCLC) patientsWanyuan Cui, Charlotte Milner-Watts, Hazel O'Sullivan, et al.
Cell Reports. Medicine|October 10, 2023
MesoGraph: Automatic profiling of mesothelioma subtypes from histological imagesMark Eastwood, Heba Sailem, Silviu Tudor Marc, et al.
Artificial Intelligence in Medicine|September 6, 2023
Malignant Mesothelioma subtyping via sampling driven multiple instance prediction on tissue image and cell morphology dataMark Eastwood, Silviu Tudor Marc, Xiaohong Gao, et al.
Lung Cancer (Amsterdam, Netherlands)|January 27, 2022
A pilot of Blood-First diagnostic cell free DNA (cfDNA) next generation sequencing (NGS) in patients with suspected advanced lung cancerWanyuan Cui, Charlotte Milner-Watts, Terri P McVeigh, et al.
BMC Cancer|March 9, 2021
Correction to: Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic diseaseDearbhaile Catherine Collins, Raghav Sundar, Anastasia Constantinidou, et al.
Clinical Lung Cancer|July 11, 2017
LUME-Meso: Design and Rationale of the Phase III Part of a Placebo-Controlled Study of Nintedanib and Pemetrexed/Cisplatin Followed by Maintenance Nintedanib in Patients With Unresectable Malignant Pleural MesotheliomaGiorgio V Scagliotti, Rabab Gaafar, Anna K Nowak, et al.
BMC Cancer|December 10, 2020
Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic diseaseDearbhaile Catherine Collins, Raghav Sundar, Anastasia Constantinidou, et al.
Lung Cancer (Amsterdam, Netherlands)|January 15, 2026
Nintedanib as switch maintenance treatment in malignant pleural mesothelioma (NEMO): A double-blind randomized phase II trial (EORTC-08112-LCG)Omar Abdel-Rahman, Paul Taylor, Mary O'Brien, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 16, 2016
A Validation Study for the Use of ROS1 Immunohistochemical Staining in Screening for ROS1 Translocations in Lung CancerPatrizia Viola, Manisha Maurya, James Croud, et al.
Oncology|April 16, 2016
Characterisation of the Phosphatidylinositol 3-Kinase Pathway in Non-Small Cell Lung Cancer Cells Isolated from Pleural EffusionsMartina Puglisi, Adam Stewart, Parames Thavasu, et al.
Pageof 28